HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$17.38 USD
+0.57 (3.39%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.39 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
HUTCHMED (HCM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$26.38 | $39.00 | $17.50 | 56.93% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for HUTCHMED comes to $26.38. The forecasts range from a low of $17.50 to a high of $39.00. The average price target represents an increase of 56.93% from the last closing price of $16.81.
Analyst Price Targets (4 )
Broker Rating
HUTCHMED currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/25/2024 | Goldman Sachs | Paul K Choi | Hold | Hold |
6/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $26.38 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | NA |
HCM FAQs
HUTCHMED (China) Limited Sponsored ADR (HCM) currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for HUTCHMED (China) Limited Sponsored ADR (HCM) is $26.38. The current on short-term price targets is based on 4 reports.
The forecasts for HUTCHMED (China) Limited Sponsored ADR (HCM) range from a low of $17.5 to a high of $39. The average price target represents a increase of $51.78 from the last closing price of $17.38.
The current UPSIDE for HUTCHMED (China) Limited Sponsored ADR (HCM) is 51.78%
Based on short-term price targets offered by four analysts, the average price target for HUTCHMED comes to $26.38. The forecasts range from a low of $17.50 to a high of $39.00. The average price target represents an increase of 56.93% from the last closing price of $16.81.